Author

Elana Kertzman

Queen's University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Carla E. Gallardo-Flores· 1 shared Che C. ColpittsiD· 1 shared Lindsay L. Yu· 1 shared Paul RothhaariD· 1 shared Volker LohmanniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Carla E. Gallardo-Flores

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Hepatitis C virus NS5A is not an effective antagonist of the canonical PKR-eIF2α pathway

Carla E. Gallardo-Flores, Lindsay L. Yu, Elana Kertzman, Paul Rothhaar, Volker Lohmann, Che C. Colpitts

This study shows that HCV NS5A does not inhibit the PKR-eIF2 pathway, contradicting previous claims and supporting that HCV replicates despite active PKR response.

bioRxiv · Oct 8, 2026 · PreprintMicrobiology